Janus Henderson Group’s Revolution Medicines RVMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$950M	Sell	9,766,496 -2,537,006	-21%	-$256M	0.45%	42
2025 Q4	$980M	Buy	12,303,502 +947,448	+8%	+$62.1M	0.44%	42
2025 Q3	$530M	Buy	11,356,054 +765,327	+7%	+$30M	0.24%	93
2025 Q2	$390M	Buy	10,590,727 +400,656	+4%	+$15.4M	0.19%	118
2025 Q1	$381M	Buy	10,190,071 +706,072	+7%	+$28.7M	0.21%	116
2024 Q4	$415M	Buy	9,483,999 +3,346,755	+55%	+$169M	0.21%	110
2024 Q3	$278M	Buy	6,137,244 +1,497,026	+32%	+$65.2M	0.14%	159
2024 Q2	$180M	Buy	4,640,218 +728,099	+19%	+$27.2M	0.1%	184
2024 Q1	$126M	Buy	3,912,119 +1,712,639	+78%	+$50.8M	0.07%	236
2023 Q4	$63.1M	Sell	2,199,480 -41,259	-2%	-$991K	0.04%	332
2023 Q3	$62M	Buy	2,240,739 +922,897	+70%	+$27.4M	0.04%	326
2023 Q2	$35.2M	Buy	1,317,842 +965,014	+274%	+$23.7M	0.02%	461
2023 Q1	$7.64M	Buy	352,828 +343,212	+3,569%	+$8.45M	0.01%	763
2022 Q4	$229K	Buy	+9,616	New	+$204K	﹤0.01%	2118
2022 Q2	–	Sell	-9,668	Closed	-$246K	–	2670
2022 Q1	$246K	Buy	9,668 +2	+0%	+$44	﹤0.01%	2341
2021 Q4	$243K	Buy	+9,666	New	+$272K	﹤0.01%	2299